Literature DB >> 10803206

[Acetylcholine receptor knockout mice].

T Mitsui1.   

Abstract

To identify the functions of nicotinic or muscarinic acetylcholine receptor (nAChR or mAChR) subtypes, mice lacking beta 2 nAChR, alpha 4 nAChR, alpha 7 nAChR, M1 mAChR, and M2 mAChR have been generated. All these mice grow to normal size, and show no obvious physical or neurological deficit. However, pharmacological, biochemical, electrophysiological, neuroanatomical, and behavioural analyses revealed important functions of these AChR subunits. The beta 2 nAChR is most widely expressed in the central nervous system, and is involved in the functional high-affinity nicotine receptor regulating cognitive performance and the mesolimbic dopamine system. Aged beta 2-/- mutant mice showed neocortical degeneration and impaired spatial learning, and may serve as one possible animal model for dementias. The alpha 4 nAChR is associated mainly with the beta 2 subunit, and may form a component of the nicotinic pain pathways modulating the antinociceptive effect of nicotine. The alpha 7 nAChR mediates fast nicotinic currents in the hippocampus, and is not essential for normal neuronal development nor neurological function. The M1 mAChR mediates M current modulation in sympathetic neurons and the induction of seizure activity in the pilocarpine model of epilepsy. The M2 mAChR functions in the extrapyramidal system, hypothalamus, and spinal and/or spraspinal muscarinic pain pathways, and is possibly involved in locomotor performance, temperature control, and antinociceptive responses, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10803206

Source DB:  PubMed          Journal:  Nihon Shinkei Seishin Yakurigaku Zasshi        ISSN: 1340-2544


  1 in total

1.  Involvement of hippocampal acetylcholinergic receptors in electroacupuncture analgesia in neuropathic pain rats.

Authors:  Shu Ping Chen; Yu Kan; Jian Liang Zhang; Jun Ying Wang; Yong Hui Gao; Li Na Qiao; Xiu Mei Feng; Ya Xia Yan; Jun Ling Liu
Journal:  Behav Brain Funct       Date:  2016-04-12       Impact factor: 3.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.